European Endocrinology would like to welcome members of the endocrinology community to
contribute articles to the 2018 Spring edition. The journal is dedicated to publishing articles that
provide practical guidance and advice on topical issues, to help physicians in their day-to-day
We encourage authors to submit original research, review articles and editorials across all areas of
diabetes, obesity and endocrinology for consideration. We are particularly interested in reports of
real-world studies, along with concise review articles to summarise the latest clinical trial data and
developments in the field. Authors can submit their manuscript through the Editorial Manager portal
(details below) and the journal’s editor is pleased to receive pre-submission enquiries. Accepted
articles are published open access both in print and online, and authors have the opportunity to
publish accompanying multimedia content.
We look forward to working with you.
Abd Tahrani (Editor-in-Chief) and the European Endocrinology Team
Share this Article
Related Content In General Endocrinology
Endocrine and Metabolic Manifestations of Tuberculosis
US Endocrinology. 2020;16(2):88–96 DOI: https://doi.org/10.17925/USE.2020.16.2.88
Tuberculosis (TB) is a major public health concern in low- and middle-income countries (LMICs) of Asia and Africa, which have a high burden of human immunodeficiency virus (HIV) infection and malnutrition. It is epidemic in these regions being associated with high rates of morbidity and mortality.1 Though, TB incidence is declining at about 2% per year […]
Foreword: European Endocrinology 16.2
Welcome to the latest edition of European Endocrinology. The impacts of the COVID-19 pandemic are being felt throughout the biomedical community, and the association between diabetes and poor prognosis in COVID-19 is of particular interest to endocrinologists. We begin with an editorial by myself and Avramidis, which provides advice on the management of patients with […]
Relationship Between Statin-associated Muscle Symptoms, Serum Vitamin D and Low-density Lipoprotein Cholesterol – A Cross-sectional Study
European Endocrinology. 2020;16(2):137–42 DOI: https://doi.org/10.17925/EE.2020.16.2.137
Statin-associated muscle symptoms (SAMS) may lead to medication non-adherence among statin users. SAMS include myalgia, myositis and rhabdomyolysis (rarely seen).1 According to a recent study conducted in India, about 22% of statin users are affected by SAMS.2 Many studies have been conducted to establish a correlation between SAMS and levels of vitamin D and creatine phosphokinase (CPK; […]
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!